STAG2 and myelodysplastic syndrome: In a multivariable regression analysis to ascertain the effect of mutations, cytogenetics, diagnostic blast count, and age at the time of MDS diagnosis, the presence of a STAG2 mutation did not reach significance as an independent predictor of MDS outcome (Fig. 4E).